We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Gastroenterology

Journal Scan / Research · August 30, 2016

High Risk of Post-Infectious IBS in Patients With Clostridium difficile Infection

Alimentary Pharmacology & Therapeutics


Additional Info

Disclosure statements are available on the authors' profiles:

Alimentary Pharmacology & Therapeutics
High Risk of Post-Infectious Irritable Bowel Syndrome in Patients With Clostridium difficile Infection
Aliment. Pharmacol. Ther. 2016 Jul 22;44(6)576–582, A Wadhwa, MF Al Nahhas, RA Dierkhising, R Patel, P Kashyap, DS Pardi, S Khanna, M Grover

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading